Both CSRE and USRT target the same underlying opportunity — U.S. listed real estate investment trusts (REITs), companies that own and operate income-producing property and pay out most of their taxable income as dividends. Yet they pursue that goal through fundamentally different structures. CSRE is an active, high-conviction fund that concentrates its bets on managers' best ideas, while USRT is a passive, low-cost vehicle spanning the broad U.S. equity REIT market. As interest-rate expectations and sector rotation reshape real estate valuations, comparing these two funds clarifies how cost, diversification, and active selection drive relative positioning for investors seeking the same asset class.
CSRE is an actively managed ETF sponsored by Cohen & Steers Capital Management. It seeks total return by investing at least 80% of net assets in income-producing common stocks and equity securities issued by real estate companies, primarily REITs and similar entities. The portfolio managers use a bottom-up, relative-value process built on a proprietary valuation model weighing price-to-net asset value (NAV), cash-flow growth, and dividend discount analysis. The fund is non-diversified and holds roughly 49 to 51 positions, with a high degree of concentration: top holdings recently included WELL (around 15%), DLR (~8%), CCI (~6%), EQIX (~5–6%), and PLD (~4%). Its net expense ratio is 0.70%, and its benchmark is the FTSE Nareit All Equity REITs Index. Launched in February 2025, CSRE is a newer entrant with a shorter public track record and turnover that has run in the low-to-mid 50% range.
USRT is a passively managed fund that seeks to track the FTSE Nareit Equity REITs 40 Act Capped Index, a diversified, market-cap-weighted benchmark of U.S.-listed equity REITs that excludes mortgage, infrastructure, and timber REITs. The fund holds approximately 126 to 127 securities and carries a 0.08% net expense ratio, among the lowest in the real estate ETF category. Its top holdings reflect the broad index: WELL (~9%), PLD (~7%), EQIX (~6%), SPG (~4.5%), DLR (~4.3%), PSA (~4%), and O (~4%). Issued by BlackRock and launched in May 2007, USRT offers deep liquidity, a long operational history, and broad sector exposure spanning specialized, healthcare, retail, residential, and industrial REITs.
U.S. REITs sit at the intersection of interest rates, credit conditions, and property-specific supply and demand. Both funds are heavily exposed to data-center and tower REITs — including DLR, EQIX, and CCI — that have benefited from sustained demand for digital infrastructure, artificial intelligence computing, and cloud connectivity. Healthcare REITs such as WELL and VTR continue to draw capital from favorable demographic trends. Meanwhile, the broader sector remains sensitive to monetary policy: higher-for-longer borrowing costs pressure property valuations and development returns, while any easing cycle typically supports REIT multiples and capital flows. Sector rotation, earnings cycles among top tenants, and elevated refinancing activity remain key catalysts and risks for both funds.
Across recent weeks and months, both CSRE and USRT have moved with the same macro forces — interest-rate expectations and the relative strength of data-center and healthcare property subsectors. Their relative positioning differs more than their broad direction. USRT's wider diversification tempers single-stock volatility and delivers beta-like exposure to the entire equity REIT complex. CSRE's concentration amplifies its exposure to its highest-conviction names, which can enhance returns when those picks outperform but also deepen drawdowns during reversals. Its active tilts toward growth-oriented, digital-infrastructure-heavy REITs and away from some benchmark stalwarts create meaningful tracking divergence from the index. Over recent market cycles, USRT's lower fee and steadier construction have supported competitive net performance, while CSRE's ability to outperform hinges on sustained success in active security selection — a demanding bar given its 0.70% expense ratio versus USRT's 0.08%.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of securities using customizable filters for industry, market capitalization, technical indicators, price patterns, and performance metrics, making it faster to surface trade ideas, breakout candidates, and emerging opportunities than manual screening. For those building a watchlist around real estate or any other sector, the screener offers an efficient, data-driven starting point.
In this ETF comparison, Tickeron's AI would likely favor USRT as the structurally stronger choice. Its 0.08% expense ratio is dramatically lower than CSRE's 0.70%, and its roughly 127 holdings provide broader diversification that reduces idiosyncratic, single-stock risk. USRT also benefits from a longer track record, deeper liquidity, and index-driven consistency that aligns with trend-following and cost-efficiency screens. While CSRE's active, high-conviction approach can generate differentiated returns, its concentration, higher cost, and shorter live history introduce measurable uncertainty. On balance, the AI verdict tilts toward USRT for its favorable blend of cost efficiency, diversification, and risk-adjusted positioning — though this reflects probabilistic analysis, not personal investment advice.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for CSRE turned positive on October 09, 2026. Looking at past instances where CSRE's MACD turned positive, the stock continued to rise in 18 of 20 cases over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on CSRE as a result. In 29 of 35 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
CSRE moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CSRE crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 8 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.
Following a +1.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where CSRE advanced for three days, in 93 of 109 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
The Aroon Indicator entered an Uptrend today. In 57 of 81 cases where CSRE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.
The 10-day RSI Indicator for CSRE moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 8 similar instances where the indicator moved out of overbought territory. In 7 of the 8 cases, the stock moved lower in the following days. This puts the odds of a move lower at 88%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSRE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
CSRE broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Moving Average Convergence Divergence (MACD) for USRT turned positive on October 09, 2026. Looking at past instances where USRT's MACD turned positive, the stock continued to rise in 42 of 45 cases over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on USRT as a result. In 69 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
USRT moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for USRT crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +2.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where USRT advanced for three days, in 261 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Aroon Indicator entered an Uptrend today. In 248 of 310 cases where USRT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.
The 10-day RSI Indicator for USRT moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 23 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 50-day moving average for USRT moved below the 200-day moving average on November 04, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where USRT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
USRT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
| CSRE | USRT | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 88% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 73% | 1 day ago 75% |
| Momentum ODDS (%) | 1 day ago 83% | 1 day ago 82% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 84% | 1 day ago 84% |
| TrendMonth ODDS (%) | 1 day ago 84% | 1 day ago 82% |
| Advances ODDS (%) | 1 day ago 85% | 8 days ago 84% |
| Declines ODDS (%) | 6 days ago 69% | 6 days ago 82% |
| BollingerBands ODDS (%) | 1 day ago 80% | 1 day ago 80% |
| Aroon ODDS (%) | 1 day ago 70% | 1 day ago 80% |
A.I.dvisor indicates that over the last year, CSRE has been closely correlated with CUBE. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CSRE jumps, then CUBE could also see price increases.
| Ticker / NAME | Correlation To CSRE | 1D Price Change % | ||
|---|---|---|---|---|
| CSRE | 100% | +0.03% | ||
| CUBE - CSRE | 73% Closely correlated | +0.04% | ||
| EXR - CSRE | 71% Closely correlated | -0.76% | ||
| PLD - CSRE | 68% Closely correlated | -0.34% | ||
| WELL - CSRE | 68% Closely correlated | +0.47% | ||
| PSA - CSRE | 68% Closely correlated | -0.66% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LFAO | 156.76 | N/A | N/A |
| LifeX 2055 Longevity Income ETF (LFAO) | |||
| DMX | 49.08 | -0.13 | -0.26% |
| DoubleLine Multi-Sector Income ETF | |||
| RMNY | 23.74 | -0.11 | -0.46% |
| Rockefeller New York Municipal Bond ETF (RMNY) | |||
| FEMB | 28.30 | -0.26 | -0.91% |
| First Trust Emerging Markets Local Currency Bond ETF (FEMB) | |||
| PXH | 28.03 | -0.30 | -1.06% |
| Invesco RAFI Emerging Markets ETF (PXH) | |||